Min Hee Hong (Min H Hong)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 50

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancers

Cancer research communications

Journal for immunotherapy of cancer

Yonsei Cancer Center

Yonsei University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yonsei Cancer Center Mar 01 2016

South Korea

Assistant Professor :: Division of Medical Oncology, Department of Internal Medicine

Severance Hospital Mar 01 2006 - Feb 28 2010

South Korea

Medical resident :: Department of Internal Medicine

Severance Hospital Mar 01 2005 - Feb 28 2006

South Korea

Internship

Education History

Yonsei University College of Medicine Mar 01 1999 - Feb 15 2005

South Korea

PHD

Publications

Chang Gon Kim, Min Hee Hong, Da Hee Kim, Brian Hyohyoung Lee, Hyunwook Kim, Chan-Young Ock, Geoffrey Kelly, Yoon Ji Bang, Gamin Kim, Jung Eun Lee, Chaeyeon Kim, Se-Heon Kim, Hyun Jun Hong, Young Min Park, Nam Suk Sim, Heejung Park, Jin Woo Park, Chang Geol Lee, Kyung Hwan Kim, Goeun Park, Inkyung Jung, Dawoon Han, Jong Hoon Kim, Junha Cha, Hoyoung Lee, Mingu Kang, Heon Song, Chiyoon Oum, Seulki Kim, Sukjun Kim, Yoojoo Lim, Seunghee Kim-Schulze, Miriam Merad, Sun Och Yoon, Hyun Je Kim, Yoon Woo Koh, Hye Ryun Kim
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Chang Gon Kim, Min Hee Hong, Da Hee Kim, Brian Hyohyoung Lee, Hyunwook Kim, Chan-Young Ock, Geoffrey Kelly, Yoon Ji Bang, Gamin Kim, Jung Eun Lee, Chaeyeon Kim, Se-Heon Kim, Hyun Jun Hong, Young Min Park, Nam Suk Sim, Heejung Park, Jin Woo Park, Chang Geol Lee, Kyung Hwan Kim, Goeun Park, Inkyung Jung, Dawoon Han, Jong Hoon Kim, Junha Cha, Hoyoung Lee, Mingu Kang, Heon Song, Chiyoon Oum, Seulki Kim, Sukjun Kim, Yoojoo Lim, Seunghee Kim-Schulze, Miriam Merad, Sun Och Yoon, Hyun Je Kim, Yoon Woo Koh, Hye Ryun Kim
A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Myung-Ju Ahn, Kentaro Tanaka, Luis G Paz-Ares, Robin Cornelissen, Nicolas Girard, Elvire Pons-Tostivint, David Vicente Baz, Shunichi Sugawara, Manuel Cobo, Maurice Pérol, Céline Mascaux, Elena V Poddubskaya, Satoru Kitazono, Hidetoshi Hayashi, Min Hee Hong, Enriqueta Felip Font, Richard Hall, Oscar Juan Vidal, Daniel Brungs, Shun Lu, Marina-Chiara Garassino, Michael J Chargualaf, Yong Zhang, Paul Howarth, Deise Uema, Aaron E Lisberg, Jacob M Sands, null null
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Junha Cha, Da Hee Kim, Gamin Kim, Jae-Won Cho, Euijeong Sung, Seungbyn Baek, Min Hee Hong, Chang Gon Kim, Nam Suk Sim, Hyun Jun Hong, Jung Eun Lee, Martin Hemberg, Seyeon Park, Sun Ock Yoon, Sang-Jun Ha, Yoon Woo Koh, Hye Ryun Kim, Hoyoung Lee
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes. Journal for immunotherapy of cancer 12 (6) (2024)
Junha Cha, Da Hee Kim, Gamin Kim, Jae-Won Cho, Euijeong Sung, Seungbyn Baek, Min Hee Hong, Chang Gon Kim, Nam Suk Sim, Hyun Jun Hong, Jung Eun Lee, Martin Hemberg, Seyeon Park, Sun Ock Yoon, Sang-Jun Ha, Yoon Woo Koh, Hye Ryun Kim, Hoyoung Lee
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes. Journal for immunotherapy of cancer 12 (6) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young Seob Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of immune-modulatory effects of amivantamab in combination with pembrolizumab in lung and head and neck squamous cell carcinoma. Cancer research communications (2024)
Yongsik Sim, Beomseok Sohn, Sooyon Kim, Hye Ryun Kim, Min Hee Hong, Jinna Kim, Seung-Koo Lee, Sun Min Lim
Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma. Future oncology (London, England) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, Yun-Gyoo Lee, Su-Jin Shin, Beung-Chul Ahn, Sung Sook Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12). Oncoimmunology 13 (1) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Chang Gon Kim, Min Hee Hong, Da Hee Kim, Brian Hyohyoung Lee, Hyunwook Kim, Chan-Young Ock, Geoffrey Kelly, Yoon Ji Bang, Gamin Kim, Jung Eun Lee, Chaeyeon Kim, Se-Heon Kim, Hyun Jun Hong, Young Min Park, Nam Suk Sim, Heejung Park, Jin Woo Park, Chang Geol Lee, Kyung Hwan Kim, Goeun Park, Inkyung Jung, Dawoon Han, Jong Hoon Kim, Junha Cha, Hoyoung Lee, Mingu Kang, Heon Song, Chiyoon Oum, Seulki Kim, Sukjun Kim, Yoojoo Lim, Seunghee Kim-Schulze, Miriam Merad, Sun Och Yoon, Hyun Je Kim, Yoon Woo Koh, Hye Ryun Kim
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Junha Cha, Da Hee Kim, Gamin Kim, Jae-Won Cho, Euijeong Sung, Seungbyn Baek, Min Hee Hong, Chang Gon Kim, Nam Suk Sim, Hyun Jun Hong, Jung Eun Lee, Martin Hemberg, Seyeon Park, Sun Ock Yoon, Sang-Jun Ha, Yoon Woo Koh, Hye Ryun Kim, Hoyoung Lee
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes. Journal for immunotherapy of cancer 12 (6) (2024)
Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, Yun-Gyoo Lee, Su-Jin Shin, Beung-Chul Ahn, Sung Sook Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong
A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12). Oncoimmunology 13 (1) (2024)
Junha Cha, Da Hee Kim, Gamin Kim, Jae-Won Cho, Euijeong Sung, Seungbyn Baek, Min Hee Hong, Chang Gon Kim, Nam Suk Sim, Hyun Jun Hong, Jung Eun Lee, Martin Hemberg, Seyeon Park, Sun Ock Yoon, Sang-Jun Ha, Yoon Woo Koh, Hye Ryun Kim, Hoyoung Lee
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes. Journal for immunotherapy of cancer 12 (6) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Gowoon Yang, Chang Young Lee, Eun Young Kim, Chang Geol Lee, Min Hee Hong, Byung Jo Park, Hong In Yoon, Kyung Hwan Kim, Sang Hoon Lee, Hwa Kyung Byun, Jaeho Cho
Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments. Cancers 15 (8) (2023)
Bhumsuk Keam, Min Hee Hong, Seong Hoon Shin, Seong Gu Heo, Ji Eun Kim, Hee Kyung Ahn, Yun-Gyoo Lee, Keon Uk Park, Tak Yun, Keun-Wook Lee, Sung-Bae Kim, Sang-Cheol Lee, Min Kyoung Kim, Sang Hee Cho, So Yeon Oh, Sang-Gon Park, Shinwon Hwang, Byung-Ho Nam, Sangwoo Kim, Hye Ryun Kim, Hwan Jung Yun, null null
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Charles M Rudin, Stephen V Liu, Ross Andrew Soo, Shun Lu, Min Hee Hong, Jong-Seok Lee, Maciej Bryl, Daphne W Dumoulin, Achim Rittmeyer, Chao-Hua Chiu, Ozgur Ozyilkan, Melissa Lynne Johnson, Alejandro Navarro, Silvia Novello, Yuichi Ozawa, Sammi Hiu Tam, Namrata S Patil, Xiaohui Wen, Meilin Huang, Tien Hoang, Raymond Meng, Martin Reck
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Gowoon Yang, Chang Young Lee, Eun Young Kim, Chang Geol Lee, Min Hee Hong, Byung Jo Park, Hong In Yoon, Kyung Hwan Kim, Sang Hoon Lee, Hwa Kyung Byun, Jaeho Cho
Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments. Cancers 15 (8) (2023)
Changhwan Sung, Jinhyeon An, Soohyeon Lee, Jaesoon Park, Kang Seon Lee, Il-Hwan Kim, Ji-Youn Han, Yeon Hee Park, Jee Hyun Kim, Eun Joo Kang, Min Hee Hong, Tae-Yong Kim, Jae Cheol Lee, Jae Lyun Lee, Shinkyo Yoon, Chang-Min Choi, Dae Ho Lee, Changhoon Yoo, Sang-We Kim, Jae Ho Jeong, Seyoung Seo, Sun Young Kim, Sun-Young Kong, Jung Kyoon Choi, Sook Ryun Park
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer. Nature cancer (2023)
Youngtaek Kim, Joon Yeon Hwang, Dong Kwon Kim, Kwangmin Na, Seul Lee, Sujeong Baek, Seong-San Kang, Seung Min Yang, Mi Hyun Kim, Heekyung Han, Chai Young Lee, Yu Jin Han, Min Hee Hong, Jii Bum Lee, Sun Min Lim, Byoung Chul Cho, Youngjoon Park, Kyoung-Ho Pyo
Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies. Cancers 15 (18) (2023)
Hyun Ae Jung, Keon Uk Park, Sang Hee Cho, Jinyeong Lim, Keun-Wook Lee, Min Hee Hong, Tak Yun, Ho Jung An, Woong-Yang Park, Sergio Pereira, Chan-Young Ock, Bhumsuk Keam
A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17-11). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Seung Yeon Oh, You Won Lee, Eun Ji Lee, Seok-Young Kim, Young Joon Park, Seong Gu Heo, Mi Ra Yu, Min Hee Hong, John O DaSilva, Christopher Daly, Byoung Chul Cho, Sun Min Lim, Mi Ran Yun
Preclinical study of a biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jiyun Lee, Min Hee Hong, Byoung Chul Cho
Lazertinib: on the Way to Its Throne. Yonsei medical journal 63 (9) (2022)
Jae-Won Cho, Hyo Sup Shim, Chang Young Lee, Seong Yong Park, Min Hee Hong, Hoyoung Lee, Hye Ryun Kim
The importance of enhancer methylation for epigenetic regulation of tumorigenesis in squamous lung cancer. Experimental & molecular medicine 54 (1) (2022)
Young Joo Lee, Hye Ryun Kim, Min Hee Hong, Ki Hyeong Lee, Keon Uk Park, Geon Kook Lee, Hyae Young Kim, Soo-Hyun Lee, Kun Young Lim, Sung Jin Yoon, Byoung Chul Cho, Ji-Youn Han
A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation. Cancer (2022)
Seyeon Park, Chang Gon Kim, Da Hee Kim, Min Hee Hong, Eun Chang Choi, Se-Heon Kim, Young Min Park, Jinna Kim, Sun Ock Yoon, Gamin Kim, Sunhye Shin, Kyungsoo Kim, Yoon Woo Koh, Sang-Jun Ha, Hye Ryun Kim
Disproportional enrichment of FoxP3 + CD4 + regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma. Clinical and translational medicine 12 (3) (2022)
Cliff Molife, Jae Min Cho, Jennifer Lapthorn, Min Ju Kang, Yulia D'yachkova, Sangmi Kim, Sam Colman, Saerom Kim, Agota Szende, Ji Hyun Park, Hee Kyung Ahn, Min Hee Hong, Kaisa-Leena Taipale, Hye Ryun Kim
Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea. Drugs - real world outcomes (2022)
Chun-Bong Synn, Sung Eun Kim, Hee Kyu Lee, Min-Hwan Kim, Jae Hwan Kim, Ji Min Lee, Ha Ni Jo, Wongeun Lee, Dong Kwon Kim, Youngseon Byeon, Young Seob Kim, Mi Ran Yun, Chae-Won Park, Jiyeon Yun, Sangbin Lim, Seong Gu Heo, San-Duk Yang, Eun Ji Lee, Seul Lee, Hunmi Choi, You Won Lee, Jae Seok Cho, Do Hee Kim, Sungho Park, Jung-Ho Kim, Yewon Choi, Sung Sook Lee, Beung Chul Ahn, Chang Gon Kim, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Kyoung-Ho Pyo, Byoung Chul Cho
SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models. Clinical & translational immunology 11 (1) (2021)
Chun-Bong Synn, Dong Kwon Kim, Seok-Young Kim, Youngseon Byeon, Young Seob Kim, Mi Ran Yun, Ji Min Lee, Wongeun Lee, Eun Ji Lee, Seul Lee, You Won Lee, Doo Jae Lee, Hyun-Woo Kim, Chang Gon Kim, Min Hee Hong, June Dong Park, Sun Min Lim, Kyoung-Ho Pyo
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor. Yonsei medical journal 63 (1) (2021)
Soo-Mee Bang, Jin Hyoung Kang, Min Hee Hong, Jin-Seok Ahn, So Yeon Oh, Jin Ho Baek, Yoon Ji Choi, Seong Hoon Shin, Young-Joo Kim, Ha-Yeong Gil, Hyung-Eun Park, Juneyoung Lee, Eun-Lyeong Park
Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 27 (2021)
Seoyoung Lee, Hyo Sup Shim, Beung-Chul Ahn, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong
Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience. Cancer immunology, immunotherapy : CII (2021)
Beung Chul Ahn, Ji Hyun Lee, Min Hwan Kim, Kyoung-Ho Pyo, Choong-Kun Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong
Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Cancers 13 (12) (2021)
Beung Chul Ahn, Ji Hyoung Kim, Kyoung-Ho Pyo, Sun Min Lim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study. Cancers 13 (15) (2021)
Ji Hyun Lee, Seong Gu Heo, Beung-Chul Ahn, Min Hee Hong, Byoung Chul Cho, Sun Min Lim, Hye Ryun Kim
A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Cancer medicine 10 (20) (2021)
Byung Jo Park, Hyo Sup Shim, Chang Young Lee, Jin Gu Lee, Hye Ryun Kim, Sang Hoon Lee, Min Hee Hong, Seong Yong Park
Genetic Analysis and Operative Outcomes in Patients with Oncogene-Driven Advanced NSCLC Treated with Cytoreductive Surgery as a Component of Local Consolidative Therapy. Cancers 13 (11) (2021)
Jae-Won Cho, Min Hee Hong, Sang-Jun Ha, Young-Joon Kim, Byoung Chul Cho, Hoyoung Lee, Hye Ryun Kim
Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer. Experimental & molecular medicine 52 (9) (2020)
Min Hee Hong, Seong Gu Heo, Yun-Gyoo Lee, Hyo Song Kim, Keon Uk Park, Hoon-Gu Kim, Yoon Ho Ko, Ik-Joo Chung, Young Joo Min, Min Kyoung Kim, Kyu Ryung Kim, Jinseon Yoo, Tae-Min Kim, Hye Ryun Kim, Byoung Chul Cho
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma. Cancer 126 (20) (2020)
Mi Ran Yun, Dong Hwi Kim, Seok-Young Kim, Hyeong-Seok Joo, You Won Lee, Hun Mi Choi, Chae Won Park, Seong Gu Heo, Seok-Gu Kang, Sung Sook Lee, Adam J Schoenfeld, Alexander E Drilon, Hyo Sup Shim, Min Hee Hong, J Jean Cui, Hye Ryun Kim, Byoung Chul Cho
Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Jiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, Seo-Yoon Jeong, Kyoung-Ho Pyo, Chae-Won Park, Seong Gu Heo, Mi Ran Yun, Sangbin Lim, Min Hee Hong, Meena Thayu, Joshua C Curtin, Roland E Knoblauch, Matthew V Lorenzi, Amy Roshak, Byoung Chul Cho
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC. Cancer discovery 10 (8) (2020)
Sun Min Lim, Min Hee Hong, Hye Ryun Kim
Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives. Immune network 20 (1) (2020)
You Jin Chun, Jae Woo Choi, Min Hee Hong, Dongmin Jung, Hyeonju Son, Eun Kyung Cho, Young Joo Min, Sang-We Kim, Keunchil Park, Sung Sook Lee, Sangwoo Kim, Hye Ryun Kim, Byoung Chul Cho, null null
Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing. PloS one 14 (11) (2019)
Min Hee Hong, Hye Ryun Kim, Beung Chul Ahn, Su Jin Heo, Ji Hyoung Kim, Byoung Chul Cho
Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer. Yonsei medical journal 60 (6) (2019)
Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, Hyeong -Seok Joo, Mi Ran Yun, Dongmin Jung, Jiyeon Yun, Seong Gu Heo, Beung -Chul Ahn, Chae Won Park, Kyoung Ho Pyo, You Jin Chun, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma. Scientific reports 9 (1) (2019)
Min Hee Hong, Su-Jin Shin, Sung Kwan Shin, Dae Joon Kim, Jae Ill Zo, Young Mog Shim, Seung Eun Lee, Byoung Chul Cho, Seong Yong Park, Yoon-La Choi, Hye Ryun Kim
High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma. Scientific reports 9 (1) (2019)
Jiyeon Yun, Min Hee Hong, Seok-Young Kim, Chae-Won Park, Soyoung Kim, Mi Ran Yun, Han Na Kang, Kyoung-Ho Pyo, Sung Sook Lee, Jong Sung Koh, Ho-Juhn Song, Dong Kyun Kim, Young-Sung Lee, Se-Woong Oh, Soongyu Choi, Hye Ryun Kim, Byoung Chul Cho
YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (8) (2019)
Jee Won Suh, Seong Yong Park, Chang Young Lee, Seung Hwan Song, Dae Joon Kim, Hyo Chae Paik, Kyoung Young Chung, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Jin Gu Lee
Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate. PloS one 14 (3) (2019)

Min Hee Hong.css-eqlu8i{font-size:small;padding-left:4px;} (Min H Hong)

Publication Activity (10 Years)

Top Topics

Top Venues

Min Hee Hong (Min H Hong)